Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study

Clinical trial NCT03180034 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03180034
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Human Papillomavirus Infection Human Papillomavirus-Related Cervical Carcinoma

Start date: 2017-11-29
Primary completion: 2025-08-21
Enrollment: 27945

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.